INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 435m ago
HOUSE PTR35m ago
SEC 13F35m ago
ROBINHOOD CHAIN35m ago
Corporate insider
VM

Vasconcelles Michael

Head of Research and Dev.CIK 0001734755

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
171.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Day One Biopharmaceuticals, Inc.Head of Research and Dev. · Jan 30, 2026
9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D
—
106.9K sh
Apr 23, 2026
Apr 23, 2026
traded Apr 23, 2026
+0d
SEC FORM 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
4,397 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
346.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
226.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC FORM 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
114.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
171.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence